Chapter 18: Intermediate and Lateral Plate Mesoderm: Heart, Blood, and Kidneys

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome to the Deep Dive, where we crack open the most intricate instruction manuals of life and track the construction of our fundamental infrastructure.

The blueprint for a human being is wildly complex, but today we are zooming in on the heart of the operation, literally, and also the filtration systems and the transport network that make all of this sustained life possible.

We're talking about the developmental origins of three major, incredibly specialized organs.

The heart,

the entire circulatory system, and of course the kidneys.

It's a colossal feat of engineering.

It really is, starting with just these simple sheets of tissue that have to fold and fuse and enter into these really complex molecular conversations with each other.

So if you recall our embryology map, the body plan starts with the central structures.

We have the notochord and the paraxial mesoderm.

That's the tissue right next to the midline.

And that forms the axis, right?

The backbone, the muscle blocks, the somites.

Exactly.

But the rest of the body, well, it has to come from somewhere.

And that's where we journey today, a little more laterally.

We are focusing on the intermediate mesoderm, or IM, and the lateral plate mesoderm, the LPM.

These are the tissues that really fan out around the sides and the front of the developing embryo.

So starting just lateral to that paraxial mesoderm, we hit the IM.

What's its mandate?

What's its job?

The intermediate mesoderm is primarily responsible for building the urogenital system.

The whole thing.

The whole thing.

That means the entire kidney lineage,

the gonads, so ovaries and tests and all the ducts that are associated with them.

It also gives rise to the outer layer, the cortex of the adrenal gland.

So IM is our filtration and reproductive system builder.

In a nutshell, yes.

And the LPM being the furthest out, I'm guessing that makes it the transport and containment specialist?

Exactly.

The lateral plate mesoderm is the source of these immense structures required for circulation.

So you're talking about the heart, all the blood vessels, and the blood cells themselves.

And importantly, it's also the tissue that splits to form the of our body cavities, the coelum, and contributes to the internal skeleton of the limbs and the pelvis.

So our mission today is to follow these two mesodermal branches as they construct these core life support systems, the kidney, the heart, and that whole circulatory network.

Right.

And we're going to unpack the reciprocal inductions, the specific signaling molecules, and really get into the precise cause and effect chains that turn simple mess and chyme into,

high -pressure pumps and nanoscale filters.

Before we jump into specific organ development, let's look at that initial decision.

How does the mesoderm know if it's supposed to be paraxial, intermediate, or lateral plate in the first place?

Okay, that's a great place to start.

It's all about spatial determination.

It has to be related to the center of the embryo, right?

I mean, it seems logical that the environment closer to the midline sends out some kind of signal, and that signal just weakens the further out you go.

That's exactly the theory.

It's a classic application of a morphogen gradient, and in this case, it specifically involves bone morphogenetic proteins, or BMPs.

So the identity of the mesoderm along that medial lateral axis, from the center to the side, is believed to be specified by increasing concentrations of BMPs.

The lateral edge, the LPM, gets the highest dose of BMP4.

So proximity to the axis means low BMP, which results in paraxial mesoderm, and distance means high BMP, resulting in lateral plate mesoderm.

How does that difference in BFT concentration translate into such, I mean, dramatically different fakes?

It immediately kicks off the differential expression of transcription factors.

For instance, in those lateral regions where BMP4 is high, you see the expression of FOXF1, and this specifies the lateral plate and even the extra embryonic mesoderm.

But closer to the center, in that paraxial region, you find FOXY1 and FOXY2 being expressed instead.

And we know this switch is definitive because researchers have shown that if you get rid of the factors for that medial identity, the tissue sort of defaults to more lateral identity.

That's a brilliant piece of experimental evidence.

When researchers deleted both the FOXY1 and FOXY2 genes in mice,

the paraxial mesoderm, the tissue that should have become snow mites, our muscle and skeletal building blocks, it completely re -specified its identity.

So what did it turn into?

It started expressing Pax2, which is a major homeodomain transcription factor characteristic of the intermediate mesoderm lineage.

Wow.

So that single experiment demonstrates that this initial medialateral fate is regulated by a really strict molecular hierarchy, and it's all responding to those initial BMP sickle.

So if the transcription factor for the central fate is missing, the tissue just moves one step outward along the fate map and says, okay, I guess I'm intermediate mesoderm now.

That's a perfect way to put it.

The BMP ingredient establishes the map, and the transcription factors are the street signs.

That's fascinating.

So now that we know how the intermediate mesoderm is specified, let's follow its developmental path.

We begin with the kidney, the body's ultimate filtration and homeostatic system.

We opened by quoting Homer Smith, the great physiologist who called the kidneys the major foundation of our philosophical freedom.

That's high praise.

It is.

But when you think about it, they manage blood volume, blood pressure, the balance of every ion, the disposal of waste.

It gives us the stability we need for every other thought and action.

It really is the master regulator.

And the functional unit of the kidney, the nephron, is just an astonishing microscopic feat of architecture.

Just one nephron.

One nephron contains over 10 ,000 cells of at least a dozen different cell types, all perfectly organized along this tubule's length for filtration, reabsorption, secretion.

But developing this complex structure requires mammals to what run through two earlier sort of transient prototypes first.

Yeah, we don't jump straight to the final product.

We need test models.

The three stages move sequentially from anterior to posterior along the intermediate mesoderm.

Okay, stage one, the pronephrous.

This is the earliest, most transient form.

Around day 22 in human development, the pronephric duck arises in the intermediate mesoderm, just ventral to the anterior somites.

This duct then migrates caudally, so towards the tail, and it induces a few very rudimentary tubules in the mesenchyme right next to it.

And this pronephrous is functional in, say, simpler vertebrates, like fish and amphibian larvae, but not in amniotes like us.

Exactly.

And mammals, those tubules quickly degenerate.

But the crucial takeaway is that the main duct structure persists.

This persistent duct is absolutely essential.

And it gets a new name.

It does.

It's now referred to as the nephric duct, or sometimes you'll hear it called the wolfian duct.

And it's the highway upon which all future kidney development depends.

Which leads us to stage two, the mesenephrous, the middle kidney.

So as the pronephric tubules disappear, the middle portion of that persistent nephric duct induces a new set of tubules in the adjacent intermediate mesenchyme.

This is the mesenephrous.

In humans, only about 30 of these tubules form around day 25.

It might function transiently in filtering waste in some species, but in most mammals, its primary roles are really developmental and structural, not so much functional filtration.

And those developmental roles are incredibly important, which often gets, you know, glossed over when we're just talking about the kidney.

They are vital examples of tissue repurposing.

So, role number one.

The mesenephrous is a major, though temporary, source of hematopoietic stem cells, or HSCs.

The blood stem cells.

The very same.

These are the precursors needed to establish the early blood supply before the bone marrow niche is ready.

It's like a temporary stem cell factory in the early embryo.

And role number two relates to the future reproductive system.

Yes.

In male mammals, the mesenephrous doesn't completely regress.

Some of those tubules persist and are actually co -opted into the reproductive tract.

No way.

They become the network of tubes that transport sperm from the testes, the epididymis and the vas deferens.

In female mammals, they largely degenerate.

That's amazing.

A temporary filtration unit that also provides both the essential building blocks for blood and the permanent plumbing for the male reproductive system.

That is a multitasking organ.

And that finally brings us to the third stage, the metenephrous, which is the permanent kidney of amniotes.

This structure originates much further back in the posterior intermediate mesoderm.

And it's formed by one of the most famous examples of reciprocal induction in all developmental biology.

Classic example.

Before we get to that dialogue between the two components, let's just revisit that initial specification.

How does the intermediate mesoderm get the ability to form a kidney in the first place?

It needs an external signal, right?

Yes, it does.

And that signal comes from its immediate neighbor, the paraxial mesoderm.

Classic experiments using surgical separation in chick embryos prove that contact with the paraxial mesoderm is both necessary and sufficient for inducing this kidney -forming ability.

So if you block the contact?

If contact was blocked on one side, that side failed to form any kidney structure at all.

So the paraxial mesoderm signals you are now competent to form kidney tissue.

And that stabilizes the intermediate mesoderm's fate.

What's the molecular response that confirms that identity?

That interaction stabilizes the expression of three crucial homeodomain transcription factors.

Lim 1, Pax 2, and Pax 8.

These are the master switches.

And homeodomain factors, as a reminder, are the regulators that bind to DNA and activate whole cascades of downstream structural genes.

Exactly.

And we see how critical the stabilization is in loss -of -function experiments.

For example, if you create mice with double knockouts of both Pax 2 and Pax 8, the first essential transition needed for the pernephric duct, that mesenchymal to epithelial transition, it fails entirely.

So the cells just die.

Without this conversion, the cells undergo rapid apoptosis and no kidney structures form at all and Lim 1 is just as vital, needed for the initial duct formation and then later for forming the ureteric bud and the final nephrons.

So once that tissue is specified, the boundaries are just as important as the structure itself.

You can't have kidney tissue forming up at the neck.

So how is that anterior boundary set?

This is a beautiful chain of command that's established by spatial gradients.

The anterior boundary, where Lim 1 and Pax 2 expression suddenly stops, is set not by a lack of a signal, but by the cells losing their competence to respond to a growth factor.

And that factor is called Activen.

Activen, which is secreted by the neural tube.

So the signal might be there, but the cells in that anterior region just aren't listening.

The receptors or the internal machinery aren't ready to listen.

Precisely.

This competence is regulated by another transcription factor called HoxB4.

If the anterior intermediate mesoderm doesn't express HoxB4, it cannot respond to Activen and so those kidney transcription factors are not stabilized there.

That seems like a really elegant two -step control mechanism.

So what determines where HoxB4 is expressed?

And that's the very start of the chain.

A retinoic acid or RA gradient.

RA again.

RA, which is derived from the somites and the neural tube, acts as the original surveyor.

It establishes the boundaries along the anterior -posterior axis and that dictates where the HoxB4 expression boundary lies.

You can see the cascade.

RA sets the boundary for HoxB4, which determines the competence for Activen, which finally stabilizes PAX2 and LIM1 expression.

That chain of command brings us to the metanephrous, the permanent kidney.

Yeah.

And you said this is the quintessential example of reciprocal induction.

It is because it is built by a constant back and forth dialogue between two very distinct groups of cells.

So who are the two players in this conversation?

We have two populations, both originally derived from that intermediate mesenchyme.

One is the uretoric bud, which is an epithelial outgrowth.

And this will form the collecting ducts and the ureter itself.

Okay, that's the plumbing.

Right.

And the other is the metanephric mesenchyme, which is the loose surrounding tissue.

And this will form the entire filtering unit,

the nephron.

So Bowman's capsule, the podocytes, all the renal tubules.

All of that.

And the experimental proof that these two must talk to each other is pretty dramatic.

It is.

And we owe this fundamental understanding to Clifford Grubstein's in vitro experiments from the mid 1950s.

What did he do?

He demonstrated that if you separated the ureteric bud from the metanephric mesenchyme in a Petri dish, development just ceased instantly.

The bud stopped branching.

Amazing.

The mesenchyme, tragically, underwent massive apoptosis and just died.

They need each other for both survival and instruction.

So the mesenchyme induces the bud to grow and branch.

And in return, the bud induces the mesenchyme to survive, condense, and eventually turn into the nephron.

So let's break down the molecular steps of this dialogue.

We can start at the beginning.

How do you even create these two distinct progenitor cell types from the same starting material?

Step one, forming the progenitors.

The outline points to a subtle yet critical timing mechanism involving one's signals.

This is where we see the power of quantitative input driving a qualitative change.

The differential is driven by the duration of exposure to one's signaling.

Just how long they're exposed.

Exactly.

Both progenitor types originate from these posterior mesodermal precursors or PMPs, but their migratory timing is what matters.

Tell us about that timing differential.

The PMPs that migrate early are exposed to one's signals for only a short period.

This short exposure, followed by longer exposure to other factors like FGF9 and retinoic acid, programs them to become the urinary epithelium, the future bud.

And the mesenchyme progenitors.

The PMPs that migrate later get exposed to those one's signals for a longer sustained period.

This long exposure, followed by the FGF and RA signals, programs them to become the metnephric mesenchyme.

So that sustained -want signaling is what grants them the specific competence to respond to the ureteric bud.

It does.

It's a truly elegant solution.

The history of the cell, defined by how long it sat in a signaling bath, dictates which of the two primary organ components it becomes.

And this isn't just a theory, it's validated in a lab.

Absolutely.

When researchers culture human -induced pluripotent stem cells, IPS cells, if they give them a short one exposure, the cells differentiate into epithelial tissue.

Longer -want exposure pushes them toward the kidney -forming mesenchyme.

And when you combine these two lab -generated populations, they form kidney organoids that have all the major cell types.

So when exposure time is definitely the critical fade switch.

It is.

So once the mesenchyme has that competence, it needs to kickstart the growth of the bud.

Step two.

Mesenchyme induces the bud.

What's the key molecular handshake here?

This is the famed GDN -FRET pathway.

First, retinoic acid signaling instructs the nearby nephric duct to express the ret receptor protein on its surface.

The ret receptor is like the specific receiving antenna.

And the signal itself?

That signal is secreted by the metanephric mesenchyme.

It's GDNF, or glial -derived neurotrophic factor.

GDNF is the chemoattractive.

That's the come -here signal.

Exactly.

It binds to those ret receptors on the nephric duct cells.

And that causes a massive local proliferation and migration towards the mesenchyme.

This outgrowth is the ureteric bud.

So the red cells are essentially following the scent of GDNF.

And if either the scent or the antenna is missing, the whole process fails.

Completely.

The evidence is irrefutable.

Mice that lack the genes for either GDNF or the ret receptor die very quickly after birth from renalogenesis.

A complete failure of kidney development.

It's an absolute non -negotiable requirement.

Wow.

Okay.

So once the bud starts growing toward the mesenchyme, the mesenchyme is suddenly in danger of dying.

Which brings us to step three.

Bud rescues the mesenchyme.

Right.

If that metanephric mesenchyme is induced, but it's not immediately converted into an epithelial structure, it has to be saved from programmed cell death.

So the ureteric bud is now sending anti -epoptotic signals back to the tissue that induced it.

What are these anti -death signals?

They include FGF2 and BMP7.

And these factors don't just ensure the survival of the mesenchyme.

FGF2 also promotes the condensation of those mesenchyme cells into denser groups, and it maintains the synthesis of WT1.

And WT1 is a transcription factor.

That is absolutely necessary for the continued outgrowth and branching of the ureteric bud itself.

So the bud sends a survival signal, which in turn helps the bud keep growing.

That immediately shows the reciprocal nature of the conversation.

Now, step four.

The bud needs to branch

hundreds of thousands of times to create this massive network of collecting ducts.

And this is where we see these essential feedback loops maintaining the growth.

GDNF, which is still being secreted by the mesenchyme, now induces secondary buds to sprout once the primary bud has penetrated the mesenchyme.

This drives that extensive branching.

So the mesenchyme is constantly pulling the branches towards itself using GDNF.

But how does the system prevent runaway proliferation?

I mean, something that would turn the kidney into a disorganized mass.

That's a great question.

GDNF simultaneously induces synthesis of 1T11 in the responsive tip cells of the bud.

1T11 then reciprocates by helping to regulate the GDNF levels in the mesenchyme.

Ah, a feedback loop.

A complex feedback loop that ensures a coordinated balance between the branching of the epithelium and the proliferation of the mesenchyme.

It effectively maintains two populations of self -renewing stem cells, the bud tip cells and the mesenchyme cap cells, so the organ can continue to grow.

While the tips of the bud are branching, the mesenchyme cells that are not being maintained as stem cells have to undergo their final transformation.

So step five is the mesenchyme to nephron transition.

This is the spectacular mesenchymal epithelial transition, or MET, where this loose, unorganized tissue becomes a tightly polarized filtering tube.

And this is triggered by Wnt9b and Wnt6.

Okay.

And these are secreted from the sides of the ureteric bud branches, not the tips.

These white signals tell the nearby mesenchyme, okay, it's time to condense and polarize.

And then the transformation becomes an internal conversation within the mesenchyme itself.

Yes, once Wnt9b and Wnt6 induce the mesenchyme cells to express Wnt4.

Wnt4 then acts in an autocrine fashion, meaning the cell secretes the signal and then uses that signal itself to complete the transition.

So without Wnt4.

If mice lack Wnt4, the mesenchyme condenses but tragically fails to form the epithelia needed for filtration.

It's the final switch.

So that newly formed renal vesicle elongates into a comma shape.

Then the famous S -shaped tubule, the young nephron.

How does it physically connect to the collecting duct system?

It's a pretty dynamic process.

The connection is made when the cells of the S -shaped tubule that are closest to the ureteric bud start to actively digest the basal laminar, the basement membrane of the bud epithelium.

They just eat their way through.

They essentially migrate into that space, creating an open junction.

And this allows the fluid collected by the nephron to drain directly into the now functional collecting ducts.

Finally, step six, inserting the ureter into the bladder.

Getting this plumbing connection right is absolutely crucial for long -term health.

It is.

The stock of that original ureteric bud becomes the ureter, the tube that drains the waste to the bladder.

If this insertion is improperly positioned, it can cause urine to back up, leading to hydronephrosis and severe kidney damage.

So how does the ureter become a functional tube?

Mesenchymal cells condense specifically around the ureter stock, but not the collecting ducts.

And they become the smooth muscle of the ureter.

So it can contract.

Exactly.

Enabling the peristaltic contractions needed to push urine down.

These cells secrete BMP4, which instructs the ureter's lining to upregulate a protein called uroplakin, making the tube fully watertight.

And the bladder itself develops from the cloaca, which is a bit of a developmental joke, referencing the common waste chamber in lower vertebrates.

The term cloaca is Latin for sewer, a name from early anatomists, because this endodermal chamber at the caudal end initially receives waste from both the intestine and the temporary kidney structures.

In mammals, a septum divides the cloaca into the rectum and the urogenital sinus, which then forms the bladder and part of the urethra.

But the ureter doesn't just connect cleanly from the start.

It involves this massive rearrangement.

It does.

It originally empties into the bladder via the nephric or wolfian duct, that precursor duct we talked about.

But through the subsequent growth and expansion of the bladder, and importantly, through the targeted apoptosis of the caudal segment of that wolfian duct.

Cell death.

Right.

The ureter is eventually pulled away from the duct and moved to its final separate opening near the neck of the bladder.

This ensures the permanent separation of the urinary tract from the reproductive ducts, which is essential for adult function.

We are now shifting gears and moving laterally on our body map, from the intermediate mesoderm and filtration to the lateral plate mesoderm, the LPM.

So transport, structure, and pumping.

Exactly.

The LPM is the region furthest from the midline.

The first crucial organizational event here is the horizontal splitting or cavitation of the LPM into two distinct layers.

And this creates the body cavity.

We have a dorsal layer and a ventral layer and then the gap between them.

The dorsal layer, which lies under the ectoderm, is the somatic or parietal mesoderm.

This forms the outer body wall.

The ventral layer lying over the endoderm is the splantonic or visceral mesoderm.

And the space between them is the canelum.

The quelum, our primary body cavity, which will later subdivide into the pleural pericardial around the heart and peritoneal cavities.

And that splantonic mesoderm is the birthplace of the heart.

Given that the heart is the vertebrate embryo's first functional organ, it starts to beat even before it's fully formed.

This is the most immediate life support system the body builds.

It's astonishing how fast it organizes.

The precursor cells, known as the cardiogenic mesoderm or the heart field, migrate very early through the primitive streak and aggregate into two bilateral plates of splantonic mesoderm positioned anteriorly.

And we know something precise about the internal organization of those fields even before they fuse together.

That's right.

Lineage tracing shows that the medial lateral arrangement of those early precursor cells actually dictates the anterior -posterior axis of the future linear heart tube.

So cells starting closer to the midline end up in the middle of the heart tube and cells starting laterally end up at the ends.

You've got it.

Now the complexity of the adult four -chambered heart means these progenitors can't just be one homogenous field.

They're divided into two crucial heart fields.

Right.

The first heart field, or FHF, forms the initial scaffold.

Its cells migrate quickly and fuse at the midline to form the primary heart tube.

Its proliferative capacity is a little bit limited, so it primarily gives rise to the muscular walls of the left ventricle.

The workhorse.

The workhorse of the circulatory system.

And the second heart field, or SHF, this seems to be the engine of growth and complexity.

It is the growth engine.

The SHF is responsible for adding cells continuously to both the anterior and posterior ends of that initial tube.

Okay.

So posteriorly it adds cells that will form the atria and the right ventricle.

And anteriorly it builds the crucial outflow tract, the base of the aorta and pulmonary artery.

The continuous strategic addition of these SHF cells is what transforms that simple tube into the four -chambered, mature structure.

What I find truly incredible about the SHF is its multipotency.

I mean, it doesn't just make heart components.

No.

The second heart field is one of the most remarkable progenitor populations.

In addition to the atria, right ventricle, and outflow tract, it also contains precursors for the smooth muscles of the face, the pulmonary arteries and veins, and the mesenchym of the lungs.

That's amazing.

It highlights a deep evolutionary connection going way back to invertebrate cordates between the development of the pharynx, the heart, and the respiratory system.

The key marker for these multipotent SHF cells is the transcription factor islet 1.

So let's get to the environmental signals that direct this specialization.

Where are the accelerators and the brakes for heart formation?

Okay.

The key accelerators or promoters, they come from the anterior endoderm that's underlying the LKM.

They secrete BMPs, particularly BMP2, which strongly promotes heart and blood development.

These endodermal BMPs then induce FGF8 synthesis in the tissue right beneath the cardiogenic mesoderm, and FGF8 is the molecular switch that activates the synthesis of cardiac -specific proteins.

So BMP2 and FGF8 are pushing the cell toward a cardiac fate.

Yeah.

Now what about the brakes?

We need tight boundaries?

We need multiple brakes to ensure the heart forms only in that precise anterior lateral location.

So medially, the notochord secretes the BMP antagonist noggin and cordon.

So they block the BMPs?

They block BMP signaling centrally, preventing heart formation near the midline where the neural tube and notochord are.

So the midline is protected from becoming a heart.

What about the posterior border?

Posteriorly, we have WANT proteins, specifically WANT3A and WANT8 secreted by the neural tube.

These WANT signals actively inhibit heart formation.

But WANTs promote blood formation in other areas, don't they?

They do.

It's a great example of context -dependent signaling.

So this means the heart is specified only in this relatively narrow zone where the BMP activators are strong enough and the WANT antagonists are winning the fight.

How are the WANTs antagonized?

The anterior endoderm secretes its own WANT inhibitors like Cerberus, Dikoff, and Crescent.

So the cardiac precursor cells are specified only where BMP promoters from the mesoderm and endoderm coincide with the high concentration of WANT antagonists from that anterior endoderm.

It's a marvel of spatial restriction.

Once that signal environment activates the cells,

what are the pivotal transcriptional switches inside the cardiogenic mesoderm?

The first, and arguably the most important, is NKIS2 -5.

This is activated by BMPs in the absence of white signaling.

It's incredibly conserved.

Its homolog in the food fly is called Tin Man.

And if you mutate it, you get a fly with no heart structure whatsoever.

NKIS2 -5 is essential for forming the heart, but it also has a regulatory role.

It helps limit the number of precursors by downregulating BMPs itself.

Ah, that feedback mechanism is crucial.

If the heart precursor number isn't limited, what happens?

If NKIS2 -5 is conditionally knocked out in the ventricular lineage, those cells start expressing extremely high levels of BMP10, a proliferative signal.

The result is just this massive disorganized overgrowth of the ventricles.

It basically fills the chambers with muscle cells and destroys the organ's function.

So NKIS2 -5 is the chord meter.

It ensures appropriate size and structure.

And what about MESP -1?

MESP -1 cooperates with NKIS2 -5 to activate that whole cascade of cardiac -specific genes.

But its critical secondary function is to repress other potential fates.

It locks the cell into the cardiac destiny by repressing genes like brachiori and goose coid, which would otherwise shunt those precursors toward forming somites or endoderm.

After this precise specification, the two bilateral heart fields have to migrate and fuse to form a single functional tube.

What's directing this complex migration?

The foregut endoderm acts as the guide.

It secretes a crucial protein, fibronectin, forming an anterior to posterior gradient that directs the cardiac cells inward.

So if you block fibronectin, the migration just stops.

As the embryo folds laterally, the foregut essentially pulls the two cardiac tubes together, fusing them at the midline around the 7 -somite stage in chicks.

The consequence of failure here is one of the most famous examples of developmental arrest, cardiobifida.

Yes.

If you surgically prevent the fusion of the two lateral plates, you get cardiobifida II separate, small hearts beating independently on either side of the chest.

And this can happen naturally?

It can if the endoderm, which is directing the movement, is defective.

We see this in zebrafish mutations like Faust, which is a GATA -5 protein, or mouse mutations like FOXB4, these defects in the endoderm prevent the fields from merging, demonstrating the endoderm's absolute necessity in physically integrating the organ.

Once the tubes are fused, how does the heart get its regional identity ventricles in front, atria behind?

This is influenced heavily by the second heart field progenitors and their spatial exposure to retinoic acid, or RA.

There are higher concentrations of RA being synthesized in the posterior mesoderm.

So the cells that linger longer in that posterior region exposed to higher RA are specified differently.

Precisely.

High concentrations of RA specify those posterior SHF cells to become the inflow regions, the sinus venusus, and the atria.

RA governs the expression of hox genes that establish these identities.

Which is why RA is a notorious teratogen.

Exactly.

If a pregnant individual is exposed to excessive RA early on, it can cause an over -expansion of atrial tissue at the expense of the ventricles, severely disrupting the balance of the four chambers.

Next is the incredible morphological transformation known as looping.

The heart tube actually starts pulsating rhythmically while it is still fusing.

That's wild.

Looping is the process that rapidly takes that initial linear posterior polarity and twists it into the adult right -left polarity, placing the atria posterior and superior to the ventricles.

What initiates this looping?

Is it purely genetic or is there a physical component?

It begins right after those rhythmic contractions start, and it's thought to be driven by a combination of factors.

But crucially, the pressure generated by the blood flow itself helps drive the looping to completion.

So it's mechanotransduction.

It's a brilliant example of mechanotransduction, where physical force and fluid dynamics are translated into cellular instructions, guiding the final three -dimensional shape of the organ.

Finally, for chamber and valve differentiation, we need to talk T -box factors.

T -box factors are key transcription regulators for patterning.

TBI5 is critical for heart tube formation and specifically left ventricle development.

The wall that separates the two major pumping chambers, the ventricular septum, forms precisely at the sharp boundary between cells expressing TBI5 and those expressing its antagonist, TBI20, which is primarily active in the right ventricle.

So TBI5 sets the left ventricle boundary.

If you remove it, if you conditionally knock out TBI5 during development, the resulting ventricle completely lacks a septum.

You get a common ventricle, kind of like a lizard heart, incapable of separating oxygenated and deoxygenated blood effectively.

And in humans?

The same gene, TBI5, causes Holt -Orem syndrome in humans, which involves heart defects and upper limb abnormalities.

And how are the valves built?

Valve formation requires another epithelial mesenchymal transformation, or EMT.

The myocardium, the muscle layer, signals to the endocardium, the inner lining, to express the twist gene.

Twist initiates that EMT, causing those endocardial cells to detach, migrate into the lumen, and form the endocardial cushions, which are the precursors to the final heart valves.

The pump is built and beating.

Now we need the pipes and the fluid to fill them.

We turn to the remaining derivatives of the lateral plate mesoderm, blood vessel formation, and hematopoiesis.

Blood vessel construction is a two -phase process.

Phase one, vasculogenesis, is the de novo creation of a primary network from progenitor cells in the LPM.

And phase two?

Phase two, angiogenesis, is the complex remodeling, pruning, and expansion of that primary network into a hierarchy of arteries, veins, and capillary beds.

So let's start with vasculogenesis.

Where do the vessels and the blood cells share a common origin?

Deep within the LPM, a combination of BMP, Wnt, and notch signals activates the key transcription factor ETD2.

This converts the local mesoderm cells into hemangioblasts.

The common progenitor.

Exactly.

They are the common multipotent progenitors for both blood cells, the hematopoietic lineage, and endothelial cells, the vessel lining.

That's a powerful cell type 1 that can become the container or the cargo.

What signals drive them toward differentiation?

FGF2 is essential specifically for generating these hemangioblasts from the splenogenic mesoderm.

Once they exist, the entire process of organization relies on the VEGF vascular endothelial growth factor family.

Specifically, VEGFA and its major receptor, FLK1, are absolutely non -negotiable.

And we have clear genetic proof of their necessity.

We do.

Mice lacking either the gene for VEGFA or the FLK1 receptor completely fail to form the yolk sac blood islands.

It halts extra embryonic vasculogenesis.

And furthermore, even if endothelial cells differentiate, mice lacking FLK1 can't organize those cells into functional tube -like vessel structures.

These initial vessels, the blood islands, they aggregate first in the yolk sac.

What distinguishes the future vessel from the future blood cells within those islands?

In the blood islands, the outer layer of hemangioblasts flattens out to become the endothelial cells that line the vessel.

The central cells of the island differentiate into early blood cells.

Inside the embryo, this process forms the dorsal aorta and the first rudimentary capillary networks.

So moving to angiogenesis, how does that initial scaffold get refined and expanded into this vast complex tree structure of capillaries?

Angiogenesis is primarily driven by local tissue need, with VEGFA being the critical signal.

When a tissue experiences local hypoxia low oxygen, it secretes VEGFA to attract new blood supply by promoting vessel sprouting.

When a sprout forms, the vessel can't just disintegrate into a chaotic mess.

It needs structure.

So not all endothelial cells can respond to VEGFA and start sprouting at the same time.

This is where the highly coordinated DLL four notch mechanism comes in.

It ensures disciplined sprouting.

The endothelial cells closest to the VEGFA source differentiate into tip cells.

They're the leaders of the sprout.

They express high levels of the VEGF receptor, VEGFR2, and crucially, they express the notch ligand delta like four or DLL four.

And the DLL four signal acts on the neighbors.

Exactly.

DLL four activates the notch signaling pathway in the adjacent endothelial cells, turning them into stock cells.

And not signaling then suppresses the stock cells response to VEGFA.

So it's lateral inhibition.

It's a perfect example of lateral inhibition applied to vessel growth.

By preventing the stock cells from sprouting, the DLL four notch mechanism ensures that the vessel maintains structural integrity while only the selected tip cells follow the VEGF gradient to extend the new capillary.

Once the vessel has successfully extended, how does it mature and gain the stability it needs to handle high blood pressure?

That requires external reinforcement.

Angiopoiesins and the receptor TITU mediate the recruitment of parasites.

These are smooth muscle -like cells which wrap around the new endothelial tube, stabilizing the vessel walls and giving them strength.

It's remarkable that some areas of the body, like the transparent cornea, must actively prevent angiogenesis.

They employ highly effective anti -angiogenesis mechanisms.

The cornea stays vascular partly by preventing VEGF release and partly by secreting a soluble form of the VEGF receptor.

A decoy.

It acts as a decoy, binding to and neutralizing any stray VEGF that might wander in, preventing it from activating the real receptors on the endothelial cells.

And this mechanism provides a powerful clinical link back to the kidney.

It does.

While soluble VEGF receptor is normally produced during pregnancy to regulate vessel growth, overproduction is linked to a serious condition called preeclampsia.

So what's happening there?

When too much of the soluble receptor is circulating, it essentially starves two critical capillary beds.

The spiral arteries supplying the placenta and the capillaries within the mother's kidneys.

Wow.

And this reduction in blood supply leads to the defining symptoms of preeclampsia.

Hypertension and poor kidney function, resulting in protein in the urine and fetal distress.

Let's turn finally to hematopoiesis, the creation of the circulating blood cells themselves.

I mean, we need hundreds of billions of new cells daily, all derived from a tiny population of stem cells.

These are the pluripotent

hematopoietic stem cells or HSCs.

They have to self -renew to maintain their population while also generating all the intermediate progenitors needed for red cells, white cells and platelets.

We mentioned the mizonephros was a temporary source.

But where does the definitive adult -forming HSC population actually emerge?

This was a subject of huge debate for decades.

We now know that the precursors for the adult stem cells emerge from the aorta gonad mizonephros or AGM region, specifically from the ventral endothelium of the dorsal aorta.

So from the lining of the main artery of the embryo.

From the lining itself.

How does a simple endothelial cell lining a vessel suddenly decide to become a blood stem cell, jump out of the vessel wall and migrate to a new niche?

This is one of the most exciting recent discoveries in this field.

The transition from an endothelial cell to an HSC, often called the endothelial to hematopoietic transition, is mediated not just by chemical signals but by a mechanical transduction.

Physical force.

The physical force of the fluid shear, the friction generated by the heart beating and the blood flowing past the aortic wall is required to activate this conversion.

So the action of the newly formed heart dictates the creation of the permanent blood supply.

That is an elegant feedback loop of necessity.

Precisely.

The mechanical shear forces elevate levels of nitric oxide or NO within the endothelium.

NO in turn activates the master transcription factor RUN -ZUF1.

And RUN -ZUF1 is the critical switch.

The absolute critical switch.

Mice lacking it fail to form HSCs in the aorta, the yolk sac and the placental vessels.

The formation of our adult blood stem cells is a spectacular example of a physical force being translated directly into a genetic instruction.

Once these HSCs are formed and released from the aorta, they travel to the liver and finally they settle in the bone marrow niche.

What maintains their survival once they get there?

The environment or the niche is everything for HSC survival.

They rely on receiving stem cell factor or SEF which binds to the kit receptor protein on the HSC surface.

And where does that SEF come from?

It's secreted primarily by paravascular cells that are surrounding the bone marrow sinusoids, the capillaries of the bone marrow.

With some contribution from the local endothelial cells.

If you knock out SEF production in just these specific paravascular cells,

the HSCs perish.

And finally, how do these pluripotent HSCs decide which lineage they should follow?

Becoming a red cell versus a specific white cell.

HSCs generate progressively restricted progenitor cells like the common myeloid precursor.

The differentiation fate is determined by what are called hematopoietic inductive microenvironments or HIMs.

These are short range interactions with local stromal cells that concentrate specific cytokines and growth factors.

For instance, an HSC progenitor in a splenic environment might be pushed toward the erythroid or red blood cell lineage, while one deeper in the bone marrow might favor the granulocytic lineage.

The microenvironment dictates the fate via paracrine signaling.

So to quickly step back and just appreciate this massive coordinated construction project, we tracked how the intermediate mesoderm builds the kidney relying on that white timing differential to separate epithelial and mesenchymal progenitors.

Right, followed by the essential GDN -FRET reciprocal induction that drives all the branching and nephron formation.

And the lateral plate mesoderm creates the heart through the coordinated action of the first and second heart fields, precisely located by BMP promoters and one antagonist.

And we saw the crucial roles of MEN -kVis2 -5 in coordination and TD -Vi -5 in setting the boundaries for the ventricular septum.

Finally, the LPM also establishes the circulatory system.

Vascular genesis requires VEG -FA and the highly organized expansion, angiogenesis, relies on that DLL -4 -notch lateral inhibition system.

And most fundamentally, the permanent blood supply.

The adult HSCs emerge from the aorta where the mechanical sheer force of the heart beating activates the RUNC1 transcription factor, ensuring the supply matches the pump's demands.

That's a great summary.

This entire system, balancing pump speed, filtration and transport, is not just intellectually fascinating.

It is a high priority area of medical research.

I mean, congenital heart defects are the most common birth anomaly, and defects in renal function or blood cell production underpin massive disease burdens globally.

Absolutely.

Understanding the exact choreography that oint timing in the kidney, the NKI -2 -5 feedback loop in the heart, is the foundation for future regenerative medicine.

And that search for choreography is getting even more granular.

Throughout this discussion, we focused on transcription factors and proteins, which are encoded by only about 2 % of the human genome.

Right.

And yet our sources highlight that over 75 % of the genome is actively transcribed into non -coding RNA or NCRNA.

Right.

These are the regulatory molecules like long non -coding RNAs and microRNAs.

Exactly.

And researchers are now finding that these NCRNAs are not just background noise.

They are critical fine tuners of the gene networks we just discussed.

For example.

For example, a non -coding RNA, called Braveheart, is required for the expression of MESP1, that foundational transcription factor in the cardiovascular lineage.

Similarly, microRNAs, like MIR1, are essential for controlling the tempo of cell division in heart muscle cells.

So if the signaling proteins and transcription factors are the symphony orchestra, then these non -coding RNAs are the conductor, subtly controlling the tempo and volume of gene expression.

That's a perfect analogy.

So here is the provocative next step for you, the listener, to investigate.

If small disruptions in these non -coding RNAs, which are highly sensitive to environmental and genetic changes, are responsible for the subtle timing defects in the GDN FRET pathway of the kidney, or the slight mispositioning of the TB by 5 boundary in the heart, could the disruption of these fine -tuning NCRNAs be the root cause of many congenital anomalies that we currently cannot trace back to a major protein defect?

It adds another layer of astonishing complexity to the story of development, showing that even in the most fundamental processes, there is always a new, hidden layer of regulation to uncover.

Thank you for joining us for this deep dive into the intermediate and lateral plate messenger.

We'll see you next time.